Successful treatment of relapsed/refractory transformed aggressive B-cell lymphoma with polatuzumab vedotin combined with bendamustine and rituximab followed by non-myeloablative related HLA-haploidentical stem cell transplantation.

Kosugi, Shigeki; Kanno, Masatoshi; Inoue, Yasuyuki

Kosugi, Shigeki; Kanno, Masatoshi; Inoue, Yasuyuki.

Afiliação

Kosugi S; Department of Hematology, St. Marianna University Yokohama City Seibu Hospital, 1197-1 Yasashi-Chou, Asahi-Ku, Yokohama, Kanagawa, 241-0811, Japan.
Kanno M; Department of Hematology, St. Marianna University Yokohama City Seibu Hospital, 1197-1 Yasashi-Chou, Asahi-Ku, Yokohama, Kanagawa, 241-0811, Japan.
Inoue Y; Department of Hematology, St. Marianna University Yokohama City Seibu Hospital, 1197-1 Yasashi-Chou, Asahi-Ku, Yokohama, Kanagawa, 241-0811, Japan. ino-yasu@marianna-u.ac.jp.

Ann Hematol ; 102(11): 3277-3278, 2023 Nov.

Article em En | MEDLINE | ID: mdl-37561153

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article